Fernando José Magro Dias


AuthID: R-000-50A

Confirmed Publications: 274



61
TITLE: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in inflammatory Bowel Disease  Full Text
AUTHORS: Pinto Lopes, P; Afonso, J; Pinto Lopes, R; Rocha, C; Lago, P; Goncalves, R; De Sousa, HT; Macedo, G ; Dias, CC ; Magro, F ;
PUBLISHED: 2020, SOURCE: INFLAMMATORY BOWEL DISEASES, VOLUME: 26, ISSUE: 11
INDEXED IN: Scopus WOS
IN MY: ORCID
62
TITLE: The daily impact of COVID-19 in gastroenterology
AUTHORS: Magro, F ; Abreu, C ; Rahier, JF;
PUBLISHED: 2020, SOURCE: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, VOLUME: 8, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 33
IN MY: ORCID
63
TITLE: The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
AUTHORS: Estevinho, MM; Magro, F ;
PUBLISHED: 2020, SOURCE: GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, VOLUME: 27, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
64
TITLE: Thiopurines' Metabolites and Drug Toxicity: A Meta-Analysis
AUTHORS: Sousa, P; Estevinho, MM; Dias, CC ; Ministro, P; Kopylov, U; Danese, S; Peyrin Biroulet, L; Magro, F ;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
65
TITLE: Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties  Full Text
AUTHORS: Helena Tavares de Sousa; Maria Manuela Estevinho; Laurent Peyrin Biroulet; Silvio Danese; Claudia Camila Dias ; Fatima Carneiro ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
66
TITLE: Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease  Full Text
AUTHORS: Ferreira Duarte, M; Estevinho, MM; Duarte Araujo, M ; Magro, F ; Morato, M ;
PUBLISHED: 2020, SOURCE: INFLAMMATORY BOWEL DISEASES, VOLUME: 26, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 12
IN MY: ORCID
67
TITLE: Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis  Full Text
AUTHORS: Vermeire, S; Lukas, M; Magro, F ; Adsul, S; Lindner, D; Rosario, M; Roth, J; Danese, S;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 13
IN MY: ORCID
68
TITLE: Accuracy of the new rapid test for monitoring adalimumab levels
AUTHORS: Rocha, C; Afonso, J ; Lago, P; Arroja, B; Vieira, AI; Dias, CC ; Magro, F ;
PUBLISHED: 2019, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 12
INDEXED IN: Scopus WOS CrossRef Handle
IN MY: ORCID
69
TITLE: Anti-TNF treatment failure: drug levels, immunogenicity, or both?
AUTHORS: Magro, F ;
PUBLISHED: 2019, SOURCE: LANCET GASTROENTEROLOGY & HEPATOLOGY, VOLUME: 4, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
70
TITLE: Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One?
AUTHORS: Magro, F ; Coelho, R; Peixoto, A;
PUBLISHED: 2019, SOURCE: CURRENT MEDICINAL CHEMISTRY, VOLUME: 26, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
Página 7 de 28. Total de resultados: 274.

Um espaço para investigadores e suas instituições

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service